Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma
- First Posted Date
- 2014-01-10
- Last Posted Date
- 2023-01-20
- Target Recruit Count
- 17
- Registration Number
- NCT02032810
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Physical Activity for Advanced Stage Cancer Patients
- Conditions
- Cancer
- Interventions
- Behavioral: Six Week Physical Activity InterventionOther: Progress Reporting
- First Posted Date
- 2013-12-19
- Last Posted Date
- 2022-06-14
- Target Recruit Count
- 10
- Registration Number
- NCT02015936
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
- Conditions
- Lung CancerNon-small Cell Lung Cancer (NSCLC)
- Interventions
- First Posted Date
- 2013-12-03
- Last Posted Date
- 2020-11-27
- Target Recruit Count
- 25
- Registration Number
- NCT01999985
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Yoga for Aromatase Inhibitor-associated Joint Pain
- Conditions
- Breast Cancer
- Interventions
- Other: QuestionnairesOther: Yoga Classes
- First Posted Date
- 2013-09-27
- Last Posted Date
- 2016-07-04
- Target Recruit Count
- 16
- Registration Number
- NCT01951976
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis
- Conditions
- Graft-Versus-Host-Disease
- Interventions
- First Posted Date
- 2013-08-22
- Last Posted Date
- 2017-07-02
- Target Recruit Count
- 20
- Registration Number
- NCT01927120
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome
- First Posted Date
- 2013-06-25
- Last Posted Date
- 2015-01-12
- Target Recruit Count
- 2
- Registration Number
- NCT01886287
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection
- Conditions
- Dysphagia
- Interventions
- Procedure: DilationProcedure: Esophagogastroduodenoscopy (EGD)Other: Triamcinolone Injection
- First Posted Date
- 2013-06-10
- Last Posted Date
- 2017-10-24
- Target Recruit Count
- 10
- Registration Number
- NCT01873573
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation
- Conditions
- Non-Small Cell Lung CancerLung Cancer
- Interventions
- First Posted Date
- 2013-05-21
- Last Posted Date
- 2023-01-19
- Target Recruit Count
- 43
- Registration Number
- NCT01859026
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant
- Conditions
- Multiple Myeloma
- Interventions
- Biological: PCV 13
- First Posted Date
- 2013-05-13
- Last Posted Date
- 2017-02-02
- Target Recruit Count
- 8
- Registration Number
- NCT01852591
- Locations
- 🇺🇸
H.Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain
- Conditions
- PainUnresectable Malignant NeoplasmLymphomaCancerTumorMalignant Solid TumorNeoplasm MetastasisHematologic MalignancyMultiple Myeloma
- Interventions
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2015-06-04
- Target Recruit Count
- 9
- Registration Number
- NCT01846429
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States